These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 15754296)

  • 1. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of p63 expression on survival in oral squamous cell carcinoma.
    Lo Muzio L; Campisi G; Farina A; Rubini C; Pastore L; Giannone N; Colella G; Leonardi R; Carinci F
    Cancer Invest; 2007 Sep; 25(6):464-9. PubMed ID: 17882659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
    Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
    Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
    de Oliveira LR; Ribeiro-Silva A; Zucoloto S
    J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
    Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G
    J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma.
    Lo Muzio L; Leonardi R; Mignogna MD; Pannone G; Rubini C; Pieramici T; Trevisiol L; Ferrari F; Serpico R; Testa N; De Rosa G; Staibano S
    Anticancer Res; 2004; 24(2C):1063-9. PubMed ID: 15154624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p63 protein and mRNA in oral epithelial dysplasia.
    Chen YK; Hsue SS; Lin LM
    J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
    Chen YK; Hsue SS; Lin LM
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization.
    Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B
    Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.
    Koga F; Kawakami S; Fujii Y; Saito K; Ohtsuka Y; Iwai A; Ando N; Takizawa T; Kageyama Y; Kihara K
    Clin Cancer Res; 2003 Nov; 9(15):5501-7. PubMed ID: 14654529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
    Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
    Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitous p63 expression in human esophageal squamous cell carcinoma.
    Hara T; Kijima H; Yamamoto S; Kenmochi T; Kise Y; Tanaka H; Chino O; Shimada H; Takazawa K; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2004 Aug; 14(2):169-73. PubMed ID: 15254760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation.
    Ebrahimi M; Wahlin YB; Coates PJ; Sjöström B; Nylander K
    J Oral Pathol Med; 2006 Jan; 35(1):46-50. PubMed ID: 16393253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of immunocytochemical detection of tumor markers (XIAP, phosphohistone H1 and p63) in FNA cellblock samples from head and neck squamous cell carcinoma.
    Wu M; Kafanas A; Gan L; Kohtz DS; Zhang L; Genden E; Burstein DE
    Diagn Cytopathol; 2008 Nov; 36(11):797-800. PubMed ID: 18831009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.